Methazolamide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Oceanside Pharmaceuticals. The primary component is Methazolamide.
| Product ID | 68682-023_0962cf33-b872-4006-82f8-8610567a07d6 |
| NDC | 68682-023 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Methazolamide |
| Generic Name | Methazolamide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-10-02 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA207438 |
| Labeler Name | Oceanside Pharmaceuticals |
| Substance Name | METHAZOLAMIDE |
| Active Ingredient Strength | 50 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-10-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0574-0790 | methazolamide | methazolamide |
| 0574-0791 | methazolamide | methazolamide |
| 0781-1071 | Methazolamide | Methazolamide |
| 0781-1072 | Methazolamide | Methazolamide |
| 24208-022 | Methazolamide | methazolamide |
| 24208-023 | Methazolamide | methazolamide |
| 42571-239 | METHAZOLAMIDE | Methazolamide |
| 42571-240 | METHAZOLAMIDE | Methazolamide |
| 46672-109 | Methazolamide | methazolamide |
| 46672-110 | Methazolamide | methazolamide |
| 50090-3233 | methazolamide | methazolamide |
| 51224-024 | Methazolamide | Methazolamide |
| 51224-124 | Methazolamide | Methazolamide |
| 51407-026 | Methazolamide | Methazolamide |
| 51407-027 | Methazolamide | Methazolamide |
| 55806-020 | methazolamide | methazolamide |
| 55806-021 | methazolamide | methazolamide |
| 62559-240 | Methazolamide | Methazolamide |
| 62559-241 | Methazolamide | Methazolamide |
| 63629-1958 | Methazolamide | Methazolamide |
| 63629-1986 | Methazolamide | Methazolamide |
| 63629-1987 | Methazolamide | Methazolamide |
| 68151-3110 | Methazolamide | methazolamide |
| 68682-022 | Methazolamide | methazolamide |
| 68682-023 | Methazolamide | methazolamide |